Company Overview - Rapid Micro Biosystems, Inc. is an innovative life sciences technology company focused on providing automation solutions for the efficient manufacturing and safe release of healthcare products [3] - The company specializes in products such as biologics, vaccines, cell and gene therapies, and sterile injectables [3] - The flagship product, Growth Direct system, modernizes microbial quality control testing workflows in pharmaceutical manufacturing, enhancing speed, accuracy, and operational efficiency [3] Financial Results Announcement - The company will release its fourth quarter and full year 2024 financial results on February 28, 2025, prior to market opening [1] - A webcast conference call will be hosted by the management team at 8:00 a.m. ET on the same day, with live audio accessible on the company's website [2] Global Presence - The company is headquartered in Lexington, Massachusetts, with manufacturing operations in Lowell, Massachusetts, and additional locations in Switzerland, Germany, and the Netherlands [3]
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025